This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Anjali Narayan Avadhani: Innovator in Cancer Treatment
Introduction
Anjali Narayan Avadhani is a prominent inventor based in Chalfont, PA (US). She has made significant contributions to the field of cancer treatment, particularly through her innovative research and development efforts. With a total of 2 patents, her work is paving the way for advancements in medical therapies.
Latest Patents
One of her latest patents is titled "FGFR Tyrosine Kinase Inhibitors for the Treatment of Urothelial Carcinoma." This invention focuses on a method for treating cancer using erdafitinib, showcasing her commitment to improving patient outcomes in oncology.
Career Highlights
Anjali currently works at Janssen Pharmaceutica NV, where she continues to push the boundaries of cancer research. Her role at this leading pharmaceutical company allows her to collaborate with other experts in the field and contribute to groundbreaking treatments.
Collaborations
Some of her notable coworkers include Yohann Loriot and Anne Elizabeth O'Hagan. Their collective expertise enhances the innovative environment at Janssen Pharmaceutica NV, fostering the development of new therapies.
Conclusion
Anjali Narayan Avadhani is a dedicated inventor whose work in cancer treatment is making a significant impact. Her patents and collaborations reflect her commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile